Dakota Chase Ecklund, in Derby, KS - Licensed Practical Nurse

Dakota Chase Ecklund, is a Licensed Practical Nurse based in Derby, Kansas. Dakota Chase Ecklund is licensed to practice in Kansas (license number 23-51030-061) and his current practice location is 510 S Westview Dr, Derby, Kansas. He can be reached at his office (for appointments etc.) via phone at (316) 869-6961.

NPI number for Dakota Chase Ecklund is 1376310979 and his current mailing address is 2012 S Edmunds St, Seattle, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1376310979.

Contact Information

	Dakota Chase Ecklund,
	510 S Westview Dr, Derby, KS 67037-1340
	(316) 869-6961
	Not Available

Provider's Profile

Full Name	Dakota Chase Ecklund
Gender	Male
Speciality	Licensed Practical Nurse
Location	510 S Westview Dr, Derby, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1376310979
Provider Enumeration Date: 12/05/2023
Last Update Date: 12/05/2023

Medical Identifiers

Medical identifiers for Dakota Chase Ecklund such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1376310979	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	23-51030-061 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dakota Chase Ecklund is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dakota Chase Ecklund, 2012 S Edmunds St, Seattle, WA 98108-1927 Ph: () -	Dakota Chase Ecklund, 510 S Westview Dr, Derby, KS 67037-1340 Ph: (316) 869-6961

News Archive

Researchers look at sildenafil use in cirrhosis patients

Sildenafil is valuable in the treatment of erectile dysfunction and pulmonary hypertension in patients with end-stage liver disease through inhibition of the type-5 phosphodiesterase.

Potential drug target identified for diabetes by studying novel gut-brain-liver circuit

Scientists at the Toronto General Hospital Research Institute have discovered a novel signaling pathway between three organs - the gut, the brain, and the liver - which lowers blood sugar when activated.

FDA classifies Medtronic's Octopus Nuvo Tissue Stabilizer recall as Class I

Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.

CPM procedure may only offer survival benefit to breast cancer patients age 50 and younger

Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D. Anderson Cancer Center.

Dakota Chase Ecklund, - Licensed Practical Nurse in Derby, KS